Tango Therapeutics Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Tango Therapeutics stock has a consensus rating of "Buy" and an average price target of $31.9. The average 1-year stock price forecast is 45.13% higher than the current stock price, while the lowest is $21 (-4.46%) and the highest is $55 (+150.23%).

Price Target: $31.9 (+45.13%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$21	$31.9	$30	$55
Change	-4.46%	+45.13%	+36.49%	+150.23%

Analyst Ratings

The average analyst rating for Tango Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	8	8	9	9	10	9
Buy	1	1	1	1	1	0
Hold	1	1	1	1	1	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	11	11	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Laura Prendergast Stifel Nicolaus	Stifel Nicolaus	Buy Maintains $40	Buy	Maintains	$40	+81.98%	May 25, 2026
John Newman Canaccord Genuity	Canaccord Genuity	Buy Maintains $30	Buy	Maintains	$30	+36.49%	May 22, 2026
Joseph Catanzaro Mizuho Securities	Mizuho Securities	Buy Maintains $20 → $30	Buy	Maintains	$20 → $30	+36.49%	May 15, 2026
Kelsey Goodwin Piper Sandler	Piper Sandler	Hold Downgrades $16 → $24	Hold	Downgrades	$16 → $24	+9.19%	May 14, 2026
Andrew Berens Leerink Partners	Leerink Partners	Buy Reiterates $28 → $55	Buy	Reiterates	$28 → $55	+150.23%	May 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 62.38M

Revenue Next Year

n/a

EPS This Year

-1.35

from -0.87

EPS Next Year

-1.56

from -1.35

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	37.04M	24.86M	36.53M	42.07M	62.38M	-	-
Revenue Growth	383.83%	-32.89%	46.93%	15.17%	48.29%	-	-
EPS	-0.94	-1.23	-1.08	-1.19	-0.87	-1.35	-1.56
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	14	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.25	-1.21
Avg	-1.35	-1.56
Low	-1.58	-1.83

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.